The β-catenin-TCF/LEF complex then induces transcription of downstream target genes in cancer, such as c-Myc, cyclin D1, and Tcf-113, and subsequently lead to the transactivation of survivin promoter14. This evidence concerns the gene BIRC5 and cancer.